Association of neonatal necrotizing enterocolitis with myeloid differentiation-2 and GM2 activator protein genetic polymorphisms

Zhou,Wei; Yuan,Weiming; Huang,Longguang; Wang,Ping; Rong,Xiao; Tang,Juan

doi:10.3892/mmr.2015.3499

Association of neonatal necrotizing enterocolitis with myeloid differentiation-2 and GM2 activator protein genetic polymorphisms

Authors:
- Wei Zhou
- Weiming Yuan
- Longguang Huang
- Ping Wang
- Xiao Rong
- Juan Tang
View Affiliations

Affiliations: Department of Neonatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510120, P.R. China
Published online on: March 17, 2015 https://doi.org/10.3892/mmr.2015.3499
Pages: 974-980
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the association of neonatal necrotizing enterocolitis (NEC) with myeloid differentiation‑(MD‑2) and GM2 activator protein (GM2A) genetic polymorphisms. Gene resequencing of the MD‑2 and GM2A gene exons was performed on 42 neonates, diagnosed with NEC (NEC group), as well as in the rs11465996 locus, located in the MD‑2 gene promoter region. The aim was to detect the genetic polymorphisms present in the neonates with NEC and compare the functional polymorphic loci with 83 neonates without NEC (control group), who had been born during the same period. A polymorphic locus with abnormal frequency was detected in the exon region of the MD‑2 gene. In the NEC group, the frequency of genotypes carrying the low frequency allele (G) in the rs11465996 locus (MD‑2 promoter region) was significantly higher compared with the control group (χ2=4.388, P=0.036). Furthermore, the frequencies of genotypes carrying the low frequency A and C alleles in the rs1048719 (GM2A gene exon 1) and rs2075783 loci (GM2A intron), respectively, were significantly higher in the NEC group compared with the control group (χ2=4.316, P=0.038; and χ2=13.717, P=0.000, respectively). In addition, the rs11465996 polymorphism in the MD‑2 gene promoter region was found to be associated with the severity of NEC. Furthermore, the rs2075783 polymorphism in the GM2A gene exon 1 and the rs1048719 polymorphism in the intron region of this gene, were associated with the occurrence of NEC. The present study demonstrated that gene polymorphisms of MD‑2 and GM2A were associated with the occurrence or severity of NEC; however, further in‑depth exploration is required to clarify the associations between genetic predispositions to polymorphisms, and NEC.

View Figures

View References

1	Garland SM, Tobin JM, Pirotta M, et al: The ProPrems trial: investigating the effects of probiotics on late onset sepsis in very preterm infants. BMC Infect Dis. 11:210–215. 2011. View Article : Google Scholar : PubMed/NCBI
2	Lu P, Sodhi CP and Hackam DJ: Toll-like receptor regulation of intestinal development and inflammation in the pathogenesis of necrotizing enterocolitis. Pathophysiology. 21:81–93. 2014. View Article : Google Scholar :
3	Kim SY, Koo JE, Seo YJ, et al: Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2. Br J Pharmacol. 168:1933–1945. 2013. View Article : Google Scholar :
4	Shibata T, Motoi Y, Tanimura N, et al: Intracellular TLR4/MD-2 in macrophages senses Gram-negative bacteria and induces a unique set of LPS-dependent genes. Int Immunol. 23:503–510. 2011. View Article : Google Scholar : PubMed/NCBI
5	Akashi S, Saitoh S, Wakabayashi Y, et al: Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J Exp Med. 198:1035–1042. 2013. View Article : Google Scholar
6	Zeng L, Zhang AQ, Gu W, et al: Identification of haplotype tag SNPs within the whole myeloid differentiation 2 gene and their clinical relevance in patients with major trauma. Shock. 37:366–372. 2012. View Article : Google Scholar : PubMed/NCBI
7	Gu W, Shan YA, Zhou J, et al: Functional significance of gene polymorphisms in the promoter of myeloid differentiation-2. Ann Surg. 246:151–158. 2007. View Article : Google Scholar : PubMed/NCBI
8	Wright CS, Mi LZ, Lee S and Rastinejad F: Crystal structure analysis of phosphatidylcholine-GM2-activator product complexes: evidence for hydrolase activity. Biochemistry. 44:13510–13521. 2005. View Article : Google Scholar : PubMed/NCBI
9	Caplan MS, Simon D and Jilling T: The role of PAF, TLR and the inflammatory response in neonatal necrotizing enterocolitis. Semin Pediatr Surg. 14:145–151. 2005. View Article : Google Scholar : PubMed/NCBI
10	Frost BL and Caplan MS: Necrotizing enterocolitis: pathophysiology, platelet-activating factor and probiotics. Semin Pediatr Surg. 22:88–93. 2013. View Article : Google Scholar : PubMed/NCBI
11	Chan KL, Wong KF and Luk JM: Role of LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis: pathogenesis and therapeutic implications. World J Gastroenterol. 15:4745–4752. 2009. View Article : Google Scholar : PubMed/NCBI
12	Rigat B, Yeger H, Shehnaz D and Mahuran D: GM2 activator protein inhibits platelet activating factor signaling in rats. Biochem Biophys Res Commun. 385:576–580. 2009. View Article : Google Scholar : PubMed/NCBI
13	Hackam DJ, Good M and Sodhi CP: Mechanisms of gut barrier failure in the pathogenesis of necrotizing enterocolitis: Toll-like receptors throw the switch. Semin Pediatr Surg. 22:76–82. 2013. View Article : Google Scholar : PubMed/NCBI
14	Jain L: Necrotizing enterocolitis prevention: art or science? Clin Perinatol. 40:xiii–xv. 2013.
15	Bhandari V, Bizzarro MJ, Shetty A, et al: Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics. 117:1901–1906. 2006. View Article : Google Scholar : PubMed/NCBI
16	Prencipe G, Azzari C, Moriondo M, et al: Association between mannose-binding lectin gene polymorphisms and necrotizing enterocolitis in preterm infants. J Pediatr Gastroenterol Nutr. 55:160–165. 2012. View Article : Google Scholar : PubMed/NCBI
17	Visintin A, Iliev DB, Monks BG, et al: Md-2. Immunobiology. 211:437–447. 2006. View Article : Google Scholar : PubMed/NCBI
18	Gu W, Shan YA, Liu Q, et al: Relationship of myeloid differentiation-2 gene promoter polymorphisms with susceptivity of complications after severe trauma in Chinese Han population. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 29:484–487. 2007.In Chinese. PubMed/NCBI
19	Hamann L, Kumpf O, Muller M, et al: A coding mutation within the first exon of the human MD-2 gene results in decreased lipopolysac-charide-induced signaling. Genes Immun. 5:283–288. 2004. View Article : Google Scholar : PubMed/NCBI
20	Vasl J, Prohinar P, Gioannini TL, et al: Functional activity of MD-2 polymorphic variant is significantly different in soluble and TLR4-bound forms: decreased endotoxin binding by G56R MD-2 and its rescue by TLR4 ectodomain. J Immunol. 180:6107–6115. 2008. View Article : Google Scholar : PubMed/NCBI
21	Izumi T and Shimizu T: Platelet-activating factor receptor: gene expression and signal transduction. Biochim Biophys Acta. 1259:317–333. 1995. View Article : Google Scholar : PubMed/NCBI
22	Caplan MS, Sun XM, Hseuh W and Hageman JR: Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr. 116:960–964. 1990. View Article : Google Scholar : PubMed/NCBI
23	Caplan M, Hsueh W, Kelly A and Donovan M: Serum PAF acetylhydrolase increases during neonatal maturation. Prostaglandins. 39:705–714. 1990. View Article : Google Scholar : PubMed/NCBI
24	Soliman A, Michelsen KS, Karahashi H, et al: Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitis. PLoS One. 5:e150442010. View Article : Google Scholar : PubMed/NCBI
25	Rigat B, Reynaud D, Smiljanic-Georgijev N and Mahuran D: The GM2 activator protein, a novel inhibitor of platelet-activating factor. Biochem Biophys Res Commun. 258:256–259. 1999. View Article : Google Scholar : PubMed/NCBI
26	Shimada Y, Li YT and Li SC: Effect of GM2 activator protein on the enzymatic hydrolysis of phospholipids and sphingomyelin. J Lipid Res. 44:342–348. 2003. View Article : Google Scholar : PubMed/NCBI